TAP032 New Psychoactive Substances with Seth Fitzgerald
June 12, 2016•113 min
The emergence of new psychoactive substances (NPS) – often called “synthetic drugs,” “legal highs,” or “research chemicals” – pose a number of challenges for policymakers, media covering these issues, medical and social service providers, and people who use these substances.
Unfortunately, current media and policy responses to NPS – a broad category that includes everything from synthetic cannabinoids such as “K2”, to synthetic opioids such as fentanyl, to traditional plants such as kratom – have been largely fueled by misinformation rather than facts. For example, in New York City, concerns about synthetic cannabinoids led to misleading media coverage and targeted policing in communities of color and among the homeless, missing a critical opportunity to lead with harm reduction and public health strategies instead of criminalization.
These substances often come on the market as legal alternatives to illicit drugs. In the U.S., they are routinely banned, leading chemists to come up